Frazier Life Sciences Management, L.P. Mirum Pharmaceuticals, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.9 Billion
- Q2 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 6,795,121 shares of MIRM stock, worth $488 Million. This represents 18.24% of its overall portfolio holdings.
Number of Shares
6,795,121
Previous 6,795,121
-0.0%
Holding current value
$488 Million
Previous $306 Million
12.96%
% of portfolio
18.24%
Previous 19.27%
Shares
8 transactions
Others Institutions Holding MIRM
# of Institutions
230Shares Held
56.1MCall Options Held
25.3KPut Options Held
98.9K-
Janus Henderson Group PLC London, X05.24MShares$376 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$232 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$198 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$189 Million2.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.56MShares$184 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.64B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...